MMP-9 inhibitor (trial agent)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MMP-9 inhibitor (trial agent), covering 2026-04-02 to 2026-04-02. Get the full timeline:
Most recent: Clinical Trial Update: MMP-9 Inhibition for Recalcitrant Wet AMD [Phase 2]